{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:18:03Z","timestamp":1789697883210,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israeli Science Foundation","doi-asserted-by":"crossref","award":["#1462"],"award-info":[{"award-number":["#1462"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Israeli Chief Scientific Office, Ministry of Health (MOH)","award":["#5914"],"award-info":[{"award-number":["#5914"]}]},{"name":"Manackerman Charitable Trust (DS)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.biochi.2013.08.024","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T02:18:45Z","timestamp":1378261125000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The effect of small molecules on nuclear-encoded translation diseases"],"prefix":"10.1016","volume":"100","author":[{"given":"Devorah","family":"Soiferman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oshrat","family":"Ayalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Saada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2013.08.024_bib1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.bbabio.2011.06.010","article-title":"Human diseases with impaired mitochondrial protein synthesis","volume":"1807","author":"R\u00f6tig","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2013.08.024_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biochi.2013.08.024_bib3","first-page":"693","article-title":"Multisystem manifestations of mitochondrial disorders","volume":"256","author":"Di Donato","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.biochi.2013.08.024_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P","article-title":"Isolated complex I deficiency in children: clinical, biochemical and genetic aspects","volume":"15","author":"Loeffen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2013.08.024_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/brain\/awq320","article-title":"Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency","volume":"134","author":"Kemp","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.biochi.2013.08.024_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10545-008-1038-z","article-title":"Clinical and molecular features of mitochondrial DNA depletion syndromes","volume":"32","author":"Spinazzola","year":"2009","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.biochi.2013.08.024_bib7","first-page":"737385","article-title":"Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies","volume":"2010","author":"Smits","year":"2010","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.biochi.2013.08.024_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.bbagrm.2011.11.009","article-title":"Mechanism of protein biosynthesis in mammalian mitochondria","volume":"1819","author":"Christian","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2013.08.024_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ajhg.2012.04.011","article-title":"Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis","volume":"90","author":"Ghezzi","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","article-title":"Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy","volume":"88","author":"G\u00f6tz","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib11","doi-asserted-by":"crossref","first-page":"e1001288","DOI":"10.1371\/journal.pbio.1001288","article-title":"Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans","volume":"10","author":"Bayat","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biochi.2013.08.024_bib12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/brain\/aws070","article-title":"Leukoencephalopathy with thalamus and brainstem involvement and high lactate \u201cLTBL\u201d caused by EARS2 mutations","volume":"135","author":"Steenweg","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biochi.2013.08.024_bib13","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1093\/hmg\/dds294","article-title":"Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy","volume":"21","author":"Elo","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/humu.21562","article-title":"Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy","volume":"32","author":"Galmiche","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2013.08.024_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbadis.2013.04.014","article-title":"Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency","volume":"1832","author":"Serre","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2013.08.024_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajhg.2011.11.027","article-title":"Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis","volume":"90","author":"Weraarpachai","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ajhg.2012.08.020","article-title":"An RMND1 mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect","volume":"91","author":"Janer","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/508434","article-title":"Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs","volume":"79","author":"Smeitink","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1056\/NEJMoa041878","article-title":"Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency","volume":"351","author":"Coenen","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2013.08.024_bib20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/hmg\/ddl106","article-title":"The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1","volume":"15","author":"Antonicka","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/510559","article-title":"Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu","volume":"80","author":"Valente","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/8904_2011_107","article-title":"Infantile progressive hepatoencephalomyopathy with combined OXPHOS deficiency due to mutations in the mitochondrial translation elongation factor gene GFM1","volume":"5","author":"Balasubramaniam","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.biochi.2013.08.024_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mito.2011.09.007","article-title":"Toward genotype phenotype correlations in GFM1 mutations","volume":"12","author":"Galmiche","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biochi.2013.08.024_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.2007.053116","article-title":"Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation","volume":"44","author":"Saada","year":"2007","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ejhg.2010.214","article-title":"Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy","volume":"19","author":"Smits","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajhg.2009.08.004","article-title":"Acute infantile liver failure due to mutations in the TRMU gene","volume":"85","author":"Zeharia","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2013.08.024_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2013_230","article-title":"Mitochondrial infantile liver disease due to TRMU gene mutations: three new cases","author":"Gaignard","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.biochi.2013.08.024_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ab.2004.08.015","article-title":"Evaluation of enzymatic assays and compounds affecting ATP production in mitochondrial respiratory chain complex I deficiency","volume":"335","author":"Saada","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biochi.2013.08.024_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ymgme.2011.07.016","article-title":"The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases","volume":"104","author":"Saada","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2013.08.024_bib30","doi-asserted-by":"crossref","first-page":"e26883","DOI":"10.1371\/journal.pone.0026883","article-title":"Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound","volume":"6","author":"Golubitzky","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biochi.2013.08.024_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-022X(88)90104-2","article-title":"Evaluation of growth rate in adhering cell cultures using a simple colorimetric method","volume":"16","author":"Pelletier","year":"1988","journal-title":"J.\u00a0Biochem. Biophys. Methods"},{"key":"10.1016\/j.biochi.2013.08.024_bib32","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awg170","article-title":"Minimum birth prevalence of mitochondrial respiratory chain disorders in children","volume":"126","author":"Skladal","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.biochi.2013.08.024_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The epidemiology of mitochondrial disorders \u2013 past, present and future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl.","key":"10.1016\/j.biochi.2013.08.024_bib34","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.mito.2007.02.008","article-title":"Infantile and pediatric quinone deficiency diseases","volume":"7","author":"R\u00f6tig","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biochi.2013.08.024_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","article-title":"Review of clinical trials for mitochondrial disorders: 1997\u20132012","volume":"10","author":"Kerr","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biochi.2013.08.024_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cmet.2011.11.003","article-title":"Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders","volume":"14","author":"Djouadi","year":"2011","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biochi.2013.08.024_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells","volume":"229","author":"Corton","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biochi.2013.08.024_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In\u00a0vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biochi.2013.08.024_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biochi.2013.08.024_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","article-title":"Activation of the PPAR\/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype","volume":"8","author":"Wenz","year":"2008","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biochi.2013.08.024_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2013.08.024_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10545-011-9292-x","article-title":"Mitochondrial medicine","volume":"34","author":"Koene","year":"2011","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.biochi.2013.08.024_bib43","doi-asserted-by":"crossref","first-page":"H13","DOI":"10.1152\/ajpheart.00368.2009","article-title":"Resveratrol induces mitochondrial biogenesis in endothelial cells","volume":"297","author":"Csiszar","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biochi.2013.08.024_bib44","doi-asserted-by":"crossref","first-page":"H1876","DOI":"10.1152\/ajpheart.00375.2009","article-title":"Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells","volume":"297","author":"Ungvari","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biochi.2013.08.024_bib45","article-title":"Effect of resveratrol on cultured skin fibroblasts from patients with oxidative phosphorylation defects","author":"De Paepe","year":"2013","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biochi.2013.08.024_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/135100010X12826446921464","article-title":"Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different","volume":"15","author":"Valdecantos","year":"2010","journal-title":"Redox Rep."},{"key":"10.1016\/j.biochi.2013.08.024_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1567-7249(01)00016-2","article-title":"Ascorbate reduces superoxide production and improves mitochondrial respiratory chain function in human fibroblasts with electron transport chain deficiencies","volume":"1","author":"Sharma","year":"2001","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biochi.2013.08.024_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/carcin\/22.7.999","article-title":"Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points","volume":"22","author":"De Flora","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biochi.2013.08.024_bib49","first-page":"333","article-title":"N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria","volume":"292","author":"Miquel","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biochi.2013.08.024_bib50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2004.11.034","article-title":"Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine","volume":"38","author":"Cocco","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biochi.2013.08.024_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0006-8993(99)01819-3","article-title":"N-Acetylcysteine elicited increase in cytochrome c oxidase activity in mice synaptic mitochondria","volume":"842","author":"Mart\u00ednez Banaclocha","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2013.08.024_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.mito.2010.09.014","article-title":"Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats","volume":"11","author":"Kamboj","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biochi.2013.08.024_bib53","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-04-1906","article-title":"Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis","volume":"64","author":"Iida","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2013.08.024_bib54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1124\/dmd.108.025908","article-title":"Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection","volume":"37","author":"Kwon","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biochi.2013.08.024_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","article-title":"Clinical and experimental applications of sodium phenylbutyrate","volume":"11","author":"Iannitti","year":"2011","journal-title":"Drugs R D."},{"key":"10.1016\/j.biochi.2013.08.024_bib56","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biochi.2013.08.024_bib57","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/j.1742-4658.2007.05735.x","article-title":"4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor","volume":"274","author":"Tveten","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.biochi.2013.08.024_bib58","doi-asserted-by":"crossref","first-page":"e38113","DOI":"10.1371\/journal.pone.0038113","article-title":"Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease","volume":"7","author":"Roy","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.biochi.2013.08.024_bib59","doi-asserted-by":"crossref","DOI":"10.2174\/1381612811319280006","article-title":"Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer's disease-like phenotype of a commonly used mouse model","author":"Cuadrado-Tejedor","year":"2013","journal-title":"Curr. Pharm. Des."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908413002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908413002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T12:24:29Z","timestamp":1539433469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908413002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":59,"alternative-id":["S0300908413002964"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2013.08.024","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of small molecules on nuclear-encoded translation diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2013.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}